Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

737
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
737
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHEST: Current State and Future Considerations.

Chest·2026
Same author

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection-Reply.

Cancer discovery·2026
Same author

The Future of Lung Cancer Screening.

Archivos de bronconeumologia·2026
Same author

Volume Control Is Not Always Volume Control.

Chest·2025
Same author

Disruption of Notch1 and Gata5 in Mice Leads to Congenital Aortic Valve Disease.

JACC. Basic to translational science·2025
Same author

Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update.

Chest·2025

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K

Update on diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Uddalak Majumdar1, Peter J Mazzone

  • 1Cleveland Clinic, Integrated Hospital Care Institute (IHI), Cleveland, Ohio, USA.

Current Opinion in Pulmonary Medicine
|March 5, 2026
PubMed
Summary

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) presents with cough and lung nodules, often misdiagnosed. Increased awareness and multidisciplinary collaboration are crucial for better diagnosis and management of this rare lung disorder.

Keywords:
DOTATATEcarcinoiddiffuse idiopathic pulmonary neuroendocrine cell hyperplasianeuroendocrinesomatostatin analog

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K
Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K
Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K

Area of Science:

  • Pulmonary Medicine
  • Oncology
  • Rare Lung Diseases

Background:

  • Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare lung disorder.
  • Characterized by neuroendocrine cell hyperplasia, tumorlets, and tumors.
  • Often misdiagnosed as asthma, presenting with lung nodules, chronic cough, and airflow obstruction.

Purpose of the Study:

  • Increase awareness of DIPNECH among pulmonary clinicians.
  • Highlight the importance of recognizing DIPNECH due to increased lung nodule detection via CT scans.
  • Provide an overview of recent clinical experiences and management principles.

Main Methods:

  • Review of retrospective case series and recent clinical experiences from academic centers.
  • Analysis of diagnostic presentations, including pulmonary function tests (PFTs).
  • Discussion of imaging modalities like DOTATATE scans and somatostatin analog efficacy.

Main Results:

  • Evidence base for DIPNECH is limited but growing.
  • Clinical presentations vary, including dyspnea and restrictive PFT patterns.
  • Variability exists in diagnosis and management approaches.

Conclusions:

  • Enhanced clinician awareness of DIPNECH is essential.
  • Multidisciplinary assessment aids in guiding patient management.
  • Multicenter collaboration is needed to establish best practices for DIPNECH.